Angiotensin II type 1 receptor blockade protects endothelium-derived hyperpolarising factor-mediated relaxation in a rat model of monoarthritis

Life Sciences

Volumn 92, Issue 23, 2013, Pages 1131-1137

  Mackenzie, Andrew ^a   Dunning, Lynette ^a   Ferrell, William R ^b   Lockhart, John C ^a  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Angiotensin II type 1 receptor; Endothelium derived hyperpolarising factor; Rheumatoid arthritis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; LOSARTAN; NITRIC OXIDE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GAP JUNCTION; HEART PROTECTION; MONARTHRITIS; MYOGRAPHY; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SAPHENOUS ARTERY; SYSTEMIC CIRCULATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIES; ARTHRITIS, EXPERIMENTAL; ASPIRIN; CHARYBDOTOXIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; LOSARTAN; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; NG-NITROARGININE METHYL ESTER; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1;

RATTUS;

EID: 84878572480     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.04.011     Document Type: Article

References (39)

1. J. Bellien, C. Thuillez, and R. Joannides Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans Fundam Clin Pharmacol 22 2008 363 377
2. H.A. Bird, G.P. Le, J.S. Dixon, M.A. Catalano, A. Traficante, and L.A. Liauw A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis J Rheumatol 17 1990 603 608
3. S. Dal-Ros, C. Bronner, C. Schott, M.O. Kane, M. Chataigneau, and V.B. Schini-Kerth Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery J Pharmacol Exp Ther 328 2009 478 486
4. S. Dal-Ros, M. Oswald-Mammosser, T. Pestrikova, C. Schott, N. Boehm, and C. Bronner Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats Gastroenterology 138 2010 1574 1584
5. S.M. Day, J.C. Lockhart, W.R. Ferrell, and J.S. McLean Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation Ann Rheum Dis 63 2004 1564 1570
6. C. de Wit, and T.M. Griffith Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses Pflugers Arch 459 2010 897 914
7. S. Dhein, A. Hagen, J. Jozwiak, A. Dietze, J. Garbade, and M. Barten Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides Naunyn Schmiedebergs Arch Pharmacol 381 2010 221 234
8. J.M. Doughty, J.P. Boyle, and P.D. Langton Potassium does not mimic EDHF in rat mesenteric arteries Br J Pharmacol 130 2000 1174 1182
9. C.G. Egan, J.C. Lockhart, and W.R. Ferrell Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation J Physiol 557 2004 635 643
10. C.A. Farquharson, and A.D. Struthers Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure J Am Coll Cardiol 39 2002 767 775
11. M. Feletou, and P.M. Vanhoutte EDHF: an update Clin Sci (Lond) 117 2009 139 155
12. G.S. Firestein The T, cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis J Clin Invest 114 2004 471 474
13. I.R. Hutcheson, and T.M. Griffith Role of phospholipase A(2) and myoendothelial gap junctions in melittin-induced arterial relaxation Eur J Pharmacol 406 2000 239 245
14. Y. Kansui, K. Fujii, K. Nakamura, K. Goto, H. Oniki, and I. Abe Angiotensin II receptor blockade corrects altered expression of gap junctions in vascular endothelial cells from hypertensive rats Am J Physiol Heart Circ Physiol 287 2004 H216 H224
15. P. Kessler, R. Popp, R. Busse, and V.B. Schini-Kerth Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism Circulation 99 1999 1878 1884
16. S. Krummen, J.R. Falck, and E. Thorin Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB +/+ mice Br J Pharmacol 145 2005 264 270
17. I.A. Ku, J.B. Imboden, P.Y. Hsue, and P. Ganz Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis Circ J 73 2009 977 985
18. L. Luksha, S. Agewall, and K. Kublickiene Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease Atherosclerosis 202 2009 330 344
19. A. MacKenzie Endothelium-derived vasoactive agents, AT1 receptors and inflammation Pharmacol Ther 131 2011 187 203
20. H. Maradit-Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, and S.E. Gabriel Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis Rheum 52 2005 722 732
21. A.J. McNeish, K.A. Dora, and C.J. Garland Possible role for K + in endothelium-derived hyperpolarizing factor-linked dilatation in rat middle cerebral artery Stroke 36 2005 1526 1532
22. B. Moazed, D. Quest, and V. Gopalakrishnan Des-acyl ghrelin fragments evoke endothelium-dependent vasodilatation of rat mesenteric vascular bed via activation of potassium channels Eur J Pharmacol 604 2009 79 86
23. M.J. Mulvany, and W. Halpern Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ Res 41 1977 19 26
24. M.E. Perry, M.M. Chee, W.R. Ferrell, J.C. Lockhart, and R.D. Sturrock Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis Ann Rheum Dis 67 2008 1646 1647
25. C. Prati, A. Berthelot, B. Kantelip, D. Wendling, and C. Demougeot Treatment with the arginase inhibitor Nw-hydroxy-nor-l-arginine restores endothelial function in rat adjuvant-induced arthritis Arthritis Res Ther 14 2012 R130
26. A. Price, J.C. Lockhart, W.R. Ferrell, W. Gsell, S. McLean, and R.D. Sturrock Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis Arthritis Rheum 56 2007 441 447
27. V. Richard, S. Hurel-Merle, E. Scalbert, G. Ferry, F. Lallemand, and J.P. Bessou Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries Circulation 104 2001 750 752
28. M. Ruiz-Ortega, O. Lorenzo, Y. Suzuki, M. Ruperez, and J. Egido Proinflammatory actions of angiotensins Curr Opin Nephrol Hypertens 10 2001 321 329
29. S.L. Sandow, M. Tare, H.A. Coleman, C.E. Hill, and H.C. Parkington Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor Circ Res 90 2002 1108 1113
30. S.L. Sandow, K. Goto, N.M. Rummery, and C.E. Hill Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery J Physiol 556 2004 875 886
31. N. Sattar, D.W. McCarey, H. Capell, and I.B. McInnes Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
32. M. Toborek, and S. Kaiser Endothelial cell functions. Relationship to atherogenesis Basic Res Cardiol 94 1999 295 314
33. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, and M. Feletou Endothelial dysfunction and vascular disease Acta Physiol (Oxf) 196 2009 193 222
34. G. Vaudo, S. Marchesi, R. Gerli, R. Allegrucci, A. Giordano, and D. Siepi Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity Ann Rheum Dis 63 2004 31 35
35. S. Wallberg-Jonsson, M.L. Ohman, and S.R. Dahlqvist Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden J Rheumatol 24 1997 445 451
36. D.A. Walsh, P.I. Mapp, J. Wharton, J.M. Polak, and D.R. Blake Neuropeptide degrading enzymes in normal and inflamed human synovium Am J Pathol 142 1993 1610 1621
37. D.A. Walsh, T. Suzuki, G.A. Knock, D.R. Blake, J.M. Polak, and J. Wharton AT1 receptor characteristics of angiotensin analogue binding in human synovium Br J Pharmacol 112 1994 435 442
38. F. Wolfe, D.M. Mitchell, J.T. Sibley, J.F. Fries, D.A. Bloch, and C.A. Williams The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481 494
39. M. Yoshizumi, M.A. Perrella, J.C. Burnett Jr., and M.E. Lee Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life Circ Res 73 1993 205 209